Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease-Reference-Cited by-同舟云学术

Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease

Published:2013-06-17 Issue: Volume: Page:n/a-n/a
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Hannon Muriel,Lechanteur Chantal,Lucas Sophie,Somja Joan,Seidel Laurence,Belle Ludovic,Bruck France,Baudoux Etienne,Giet Olivier,Chantillon Anne-Marie,Delvenne Philippe,Drion Pierre,Beguin Yves,Humblet-Baron Stéphanie,Baron Frédéric

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12279/fullpdf

Reference44 articles.

1. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review;Baron;Springer Semin Immunopathol,2004

2. Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation;Weiden;N Engl J Med,1981

3. The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation;Riddell;Blood Rev,2003

4. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning;Baron;J Clin Oncol,2005

5. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation;Baron;Leukemia,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma;Experimental Hematology & Oncology;2024-06-03

2. Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHD;2024-05-02

3. A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products;Molecular Therapy - Methods & Clinical Development;2023-12

4. Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells;Immunity;2023-10

5. Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells;iScience;2023-03